liver cancer (Cancer)

Search with Google Search with Bing
Information
Disease name
liver cancer
Disease ID
DOID:3571
Description
"A hepatobiliary system cancer that is located_in the liver." [url:http\://en.wikipedia.org/wiki/Liver]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID Status Phase Summary Start date Completion date
NCT03408665 Active, not recruiting N/A Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer March 13, 2019 December 1, 2027
NCT02932956 Active, not recruiting Phase 1 Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) December 17, 2018 February 2037
NCT02716012 Active, not recruiting Phase 1 First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer March 1, 2016 December 31, 2024
NCT02523443 Active, not recruiting Phase 3 Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection August 2015 August 2024
NCT03552718 Active, not recruiting Phase 1 QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. August 10, 2018 December 30, 2025
NCT02869217 Active, not recruiting Phase 1 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors September 2016 September 2024
NCT05616039 Active, not recruiting N/A I-FIGS Feasibility Study November 23, 2022 April 30, 2024
NCT01356628 Active, not recruiting Phase 2 A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer May 25, 2011 December 31, 2024
NCT03383458 Active, not recruiting Phase 3 A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation April 18, 2018 December 16, 2025
NCT04597710 Active, not recruiting Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing February 18, 2021 December 31, 2023
NCT04682847 Active, not recruiting Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers November 19, 2020 December 31, 2024
NCT03744624 Active, not recruiting N/A Application of 3D Printing in Laparoscopic Surgery of Liver Tumors April 28, 2017 December 2022
NCT01082224 Active, not recruiting N/A Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy December 2010 December 2023
NCT05931445 Active, not recruiting N/A Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer January 26, 2021 March 31, 2027
NCT02984566 Active, not recruiting N/A Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) January 14, 2020 December 2025
NCT00582647 Active, not recruiting Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract March 2000 December 2024
NCT06315361 Active, not recruiting DIAbetes and NAFLD May 20, 2019 December 31, 2035
NCT03143270 Active, not recruiting Early Phase 1 A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer April 28, 2017 April 2025
NCT01076517 Approved for marketing A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
NCT00906984 Approved for marketing TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
NCT00012324 Completed Phase 3 Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer September 2000 November 2005
NCT00019331 Completed Phase 2 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors October 1997 May 2007
NCT00019474 Completed Phase 2 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer March 1998 August 2000
NCT00019513 Completed Phase 1 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas August 1998 June 2004
NCT00019786 Completed Phase 2 Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases August 1999 January 2006
NCT00020150 Completed Phase 1 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors June 2000
NCT00021047 Completed Phase 1/Phase 2 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor July 2001 June 2004
NCT00022334 Completed Phase 1/Phase 2 Vaccine Therapy in Treating Patients With Liver Cancer January 2001 October 2008
NCT00024258 Completed Phase 2 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors March 2001 May 2009
NCT00027534 Completed Phase 1 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer January 2002 October 2007
NCT00030082 Completed Phase 1 Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer July 2001
NCT00030108 Completed Phase 1 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy November 2001 April 2010
NCT00036959 Completed Phase 1 ABT-751 in Treating Young Patients With Refractory Solid Tumors March 2002 February 2010
NCT00040898 Completed Phase 2 Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed January 2001
NCT00041275 Completed Phase 3 Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery May 2002 August 2011
NCT00047229 Completed Phase 2 Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) October 2002 April 2009
NCT00049322 Completed Phase 2 Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery June 2003 February 2012
NCT00054262 Completed Phase 2 T900607 in Treating Patients With Unresectable Liver Cancer November 2002 September 2010
NCT00057980 Completed Phase 1/Phase 2 Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma October 2002 February 2007
NCT00058487 Completed Phase 2 Epirubicin and Thalidomide in Treating Patients With Liver Cancer December 2001 January 2007
NCT00059865 Completed Phase 1/Phase 2 Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer January 2004 February 2008
NCT00073905 Completed Phase 2 Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer April 2003 January 2009
NCT00076609 Completed Phase 1/Phase 2 Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma October 2003
NCT00077142 Completed Phase 1/Phase 2 TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) April 2001 August 2005
NCT00081094 Completed N/A Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer September 2003 September 2005
NCT00087282 Completed Phase 2 Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer June 2004 July 2006
NCT00093444 Completed Phase 1 Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors September 2004 January 2010
NCT00095992 Completed Phase 2 SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer March 8, 2005 September 22, 2008
NCT00109954 Completed Phase 3 Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery February 2005 December 2005
NCT00128596 Completed Phase 2 Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery June 2004
NCT00132041 Completed N/A Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis December 2005 November 2010
NCT00191412 Completed Phase 2 A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver January 2005 March 2006
NCT00230347 Completed Phase 1 Evaluation of Stereotactic Radiosurgery For Liver Malignancies October 2003 February 2007
NCT00242502 Completed Phase 2 Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery October 2005 October 2011
NCT00243633 Completed N/A Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS) April 2005 August 2007
NCT00654160 Completed Phase 1 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer June 2008 December 3, 2012
NCT00002515 Completed Phase 2 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer October 1992 April 2005
NCT00002608 Completed Phase 2 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors May 1994 April 2005
NCT00002655 Completed Phase 2 Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases March 1995 September 1999
NCT00003424 Completed Phase 3 Tamoxifen in Treating Patients With Primary Liver Cancer April 1997 August 2009
NCT00003427 Completed Phase 1 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer April 1998 April 2002
NCT00003557 Completed Phase 2 Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer January 1999 August 2003
NCT00003907 Completed Phase 2 Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver December 15, 1999 August 2012
NCT00003912 Completed Phase 3 Chemotherapy in Treating Children With Liver Cancer June 1998 October 2009
NCT00003923 Completed Phase 2 Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas March 1999 February 2002
NCT00004108 Completed Phase 2 DX-8951f in Treating Patients With Liver Cancer September 1999 April 2005
NCT00004136 Completed Phase 2 Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer March 9, 1998 January 25, 2006
NCT00004248 Completed Phase 2 Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery July 1999 May 2001
NCT00004604 Completed Phase 1 Biological Therapy in Treating Patients With Metastatic Cancer February 1997 July 2002
NCT00005629 Completed Phase 1/Phase 2 Vaccine Therapy in Treating Patients With Liver Cancer July 1999 June 2002
NCT00005938 Completed Phase 2 DX-8951f in Treating Patients With Biliary Cancer March 2000 April 2005
NCT00006006 Completed Phase 2 Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed August 2000
NCT00006010 Completed Phase 2 Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer September 2001 April 2008
NCT00007813 Completed Phase 1 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors May 31, 1997 February 1, 2005
NCT00009893 Completed Phase 2 Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer May 2001 October 2009
NCT00250822 Completed Phase 2 Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter October 2005 July 2006
NCT00257426 Completed Phase 2 Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer July 2005 September 2009
NCT00293397 Completed N/A Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery November 2005 April 2011
NCT00303940 Completed Phase 1 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors December 2005 February 2010
NCT00304135 Completed Phase 2/Phase 3 Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery October 2005 December 2012
NCT00310115 Completed Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy April 2002 August 2016
NCT00335829 Completed Phase 2 Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery May 2006 February 2011
NCT00361309 Completed Phase 2 SU011248 in Advanced Hepatocellular Carcinoma April 2006 March 2009
NCT00363584 Completed Phase 3 Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer March 2006
NCT00365508 Completed Phase 4 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking February 2006 August 2009
NCT00373737 Completed Microarray Analysis of Gene Expression in Liver Tumors May 1999 December 2008
NCT00374660 Completed Phase 1/Phase 2 Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors June 2003 April 2007
NCT00376987 Completed Phase 2 Zinc Supplements in Lowering Cadmium Levels in Smokers December 2003 June 2015
NCT00410956 Completed Phase 2 Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery May 9, 2007 May 7, 2024
NCT00423254 Completed Phase 1 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. February 2007 November 2009
NCT00436410 Completed Early Phase 1 Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer December 2006 August 2009
NCT00467194 Completed Phase 1 Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery December 2006
NCT00482365 Completed National Registry and Blood Bank of Patients With Liver Cancer April 2002 August 2009
NCT00482586 Completed Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy October 2003 April 2015
NCT00483405 Completed Phase 2 Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer October 2006 December 2010
NCT00486356 Completed Phase 1 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer October 1, 2004 January 1, 2010
NCT00507585 Completed Phase 1 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin June 2006 January 2010
NCT00511264 Completed Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract May 2007 May 2008
NCT00514228 Completed Phase 2 Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery July 2007 February 2009
NCT00527891 Completed Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions June 2004
NCT00530010 Completed Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery December 2004 March 8, 2022
NCT00532740 Completed Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery December 2004 March 16, 2022
NCT00534001 Completed Phase 2 Bupropion in Helping Adults Stop Smoking January 2006 July 2015
NCT00537121 Completed Phase 1 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer November 2006 June 2013
NCT00539643 Completed Phase 2 Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma November 2007 June 17, 2022
NCT00542048 Completed Phase 2 A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases November 2007 September 2009
NCT00543777 Completed Phase 1/Phase 2 Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease September 2007 January 13, 2020
NCT00574977 Completed Phase 1 Safety Study of Modified Vaccinia Virus to Cancer May 2008 July 2014
NCT00576199 Completed Phase 2 A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer February 2008 May 2011
NCT00579865 Completed Quality Of Life in Patients With Malignant Biliary Obstruction May 2005 January 2010
NCT00581815 Completed Phase 1 Spectroscopy With Surface Coils and Decoupling February 1997 February 2014
NCT00605722 Completed Phase 2 A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. March 2008 September 2010
NCT00607828 Completed N/A Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer November 16, 2007 February 15, 2017
NCT00614913 Completed Phase 1/Phase 2 Proton Beam Therapy for Treatment of Hepatocellular Carcinoma May 1998 February 2009
NCT00652132 Completed Phase 3 Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer December 15, 2007 February 28, 2018
NCT00002485 Completed Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer February 1992 September 2005
NCT00666978 Completed Phase 4 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking December 2007 June 2010
NCT00716976 Completed Phase 3 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy June 23, 2008 June 30, 2021
NCT00717756 Completed Phase 2 Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial January 2009 January 2014
NCT00728650 Completed A Retrospective Review of Malignant Liver Tumors October 2003 June 2011
NCT00732836 Completed Phase 1 Hepatic Arterial Infusion (HAI) of Abraxane June 2008 January 2016
NCT00739167 Completed Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer April 2008 May 2010
NCT00740753 Completed N/A Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option August 2004 April 28, 2021
NCT00774501 Completed N/A The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy October 2008 February 2016
NCT00777894 Completed Phase 1/Phase 2 Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery November 2008 December 2015
NCT00782886 Completed Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer April 2008 November 2010
NCT00790569 Completed N/A Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking September 2008 October 2012
NCT00825955 Completed Phase 3 Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment February 17, 2009 August 25, 2017
NCT00836992 Completed Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer January 2009 July 27, 2015
NCT00858429 Completed Phase 1 Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases April 1, 2009 July 8, 2014
NCT00866957 Completed Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) February 2006 July 2019
NCT00867321 Completed Phase 1/Phase 2 Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer April 2009 May 2013
NCT00870558 Completed Phase 3 Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer June 2005
NCT00875615 Completed Phase 2 Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery December 2008 June 2012
NCT00881751 Completed Phase 2 Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer March 2009 February 2017
NCT00888407 Completed N/A Community-based Hepatitis B Interventions for Hmong Adults September 2006 August 2011
NCT00900094 Completed UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer June 2000 October 2007
NCT00902343 Completed Phase 3 Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection May 2009 April 2015
NCT00910572 Completed Phase 2 Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma July 2007 May 2010
NCT00941967 Completed Phase 2 Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer December 2008 December 2012
NCT00949182 Completed Phase 2 Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery July 2009 June 2013
NCT00950144 Completed Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer December 2008 October 2010
NCT00956930 Completed Phase 2 Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery August 2009 July 15, 2016
NCT00957424 Completed N/A Acceptability of Less Harmful Alternatives to Cigarettes June 2009 November 2011
NCT00976898 Completed N/A Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma August 2009 July 2018
NCT00980239 Completed Phase 1 HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver September 2009 August 2015
NCT00987766 Completed Phase 1 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer November 2009 October 2016
NCT00994370 Completed Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT April 2009 January 2013
NCT01005199 Completed Phase 2 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer November 2009 March 2016
NCT01011010 Completed Phase 1 Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery July 22, 2009 September 29, 2017
NCT01033240 Completed Phase 2 CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer July 9, 2010 September 9, 2013
NCT01033695 Completed Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes January 2008 June 2009
NCT01042041 Completed Phase 1 Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer September 2009 December 2010
NCT01061840 Completed Phase 1 Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer December 2009 January 2019
NCT01075113 Completed Phase 1 Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer August 10, 2010 July 18, 2019
NCT01075399 Completed Phase 2 Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors February 2010 February 2012
NCT01075555 Completed Phase 3 Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis February 2010 September 2015
NCT01099631 Completed Phase 1 IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread April 2010 June 2014
NCT01164202 Completed Phase 2/Phase 3 Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer July 2010 July 2017
NCT01171924 Completed Phase 1 A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors July 2010 October 2011
NCT01180959 Completed Phase 2 Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy April 14, 2011 May 19, 2021
NCT01185639 Completed N/A Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer August 2010 June 27, 2016
NCT01210027 Completed A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion March 2007 April 1, 2023
NCT01213030 Completed Phase 1/Phase 2 Clinical Evaluation of the New Hypoxia Imaging Agent HX4 June 2009 May 2010
NCT01219985 Completed N/A Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver April 2008 June 2010
NCT01237990 Completed Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures August 2010 October 2011
NCT01238666 Completed Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures November 2010 March 2012
NCT01264705 Completed Phase 1/Phase 2 Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer January 2011 April 2018
NCT01283802 Completed Intraoperative Cholangio-Ultrasound in Resective Liver Surgery June 2004 June 2010
NCT01286428 Completed Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures January 2011 March 2012
NCT01313377 Completed Phase 3 Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery July 2009 June 2016
NCT01353300 Completed Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer May 2011
NCT01387555 Completed Phase 2 A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib December 2008 December 2011
NCT01401894 Completed Perception Prognosis, Goals of Treatment, and Communication October 2010 June 2014
NCT01401907 Completed N/A Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies May 2011 December 2019
NCT01434524 Completed N/A Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids April 2007 June 2011
NCT01438476 Completed Phase 3 Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas January 26, 2012 October 18, 2017
NCT01497444 Completed Phase 1 Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery May 2012 November 1, 2019
NCT01522937 Completed Phase 2 A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer October 2009 November 2015
NCT01539993 Completed Prospective Liver Study November 2008 January 2014
NCT01545804 Completed Phase 2 Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma August 2011 December 2016
NCT01556282 Completed N/A TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis March 2009 January 2014
NCT01581307 Completed Phase 2 Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets April 2012 March 2016
NCT01596283 Completed Phase 3 Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection April 2012 May 2016
NCT01658917 Completed Collecting Solid Tumor Tissue to Identify New Treatments July 24, 2012 October 23, 2017
NCT01749332 Completed N/A A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections December 2012 December 2019
NCT01853618 Completed Phase 1/Phase 2 Tremelimumab With Chemoembolization or Ablation for Liver Cancer May 2, 2013 June 7, 2017
NCT01877187 Completed Phase 2 Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer April 2013 February 2020
NCT01906021 Completed N/A Study of New Software Used During Ablations September 23, 2013 December 8, 2020
NCT01932385 Completed Phase 2/Phase 3 Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma August 1, 2013 July 30, 2016
NCT01935453 Completed Phase 1 A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer May 2012
NCT02013830 Completed Phase 2 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer May 2005 March 2008
NCT02029157 Completed Phase 3 A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) January 2014 August 2017
NCT02038296 Completed Phase 3 Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma January 2008 March 2013
NCT02069145 Completed Phase 1 Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer January 2014 July 2017
NCT02185768 Completed Phase 2 Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II January 2015 May 2018
NCT02202317 Completed N/A Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors April 2013 October 2016
NCT02202564 Completed Phase 2 Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma October 2006 August 2013
NCT02239900 Completed Phase 1 Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors August 26, 2014 October 25, 2019
NCT02264886 Completed Phase 1 Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies January 2015 December 2016
NCT02271646 Completed N/A Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation August 2014 March 2015
NCT02291133 Completed Phase 1/Phase 2 Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) June 2014 January 2020
NCT02292173 Completed Phase 1 Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer February 18, 2015 January 2021
NCT02321202 Completed Phase 4 Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer March 2010 November 2013
NCT02329106 Completed N/A Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome December 1, 2014 January 1, 2021
NCT02333279 Completed Cancer Development In Organ Transplant Recipients May 2008 July 2019
NCT02333773 Completed N/A Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli January 1, 2015 January 1, 2021
NCT02349412 Completed Phase 3 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers April 2015 July 15, 2019
NCT02424955 Completed N/A Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation November 18, 2014 June 30, 2022
NCT02425735 Completed Phase 1/Phase 2 Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer April 2015 June 2016
NCT02431676 Completed Phase 2 Survivorship Promotion In Reducing IGF-1 Trial May 2015 December 2018
NCT02447263 Completed Phase 1/Phase 2 HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer May 2015 February 2016
NCT02449109 Completed Phase 1/Phase 2 Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma May 2015 February 2016
NCT02461966 Completed N/A Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta June 2014 April 2016
NCT02465892 Completed N/A Pillars4Life Trial May 2015 October 2016
NCT02471313 Completed Phase 2 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization June 12, 2015 March 7, 2018
NCT02489422 Completed N/A Programs To Support You During Chemotherapy August 2016 January 2020
NCT02541370 Completed Phase 1/Phase 2 Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 June 2015 June 2019
NCT02545556 Completed Phase 1/Phase 2 Liver Cancer HepaSphere Combined With Cryosurgery August 2015 August 2016
NCT02649153 Completed Phase 3 Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection January 1, 2021 June 30, 2023
NCT02649868 Completed Phase 2 LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation January 12, 2016 December 2, 2023
NCT02654028 Completed N/A Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection January 5, 2019 December 30, 2021
NCT02687113 Completed N/A Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion March 2013 March 2015
NCT02753881 Completed Phase 1 Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer November 2015 December 2019
NCT02821754 Completed Phase 2 A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) July 5, 2016 December 31, 2022
NCT02829359 Completed Phase 2/Phase 3 Effects of Antiviral Therapy on HBV Reactivation July 2012 December 2015
NCT02834780 Completed Phase 1 Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma December 28, 2016 February 23, 2022
NCT02841800 Completed N/A Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis June 2016 May 10, 2019
NCT02941861 Completed Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery August 2016 September 2016
NCT02966509 Completed N/A Engagement of Patients With Advanced Cancer August 2013 December 2016
NCT03058289 Completed Phase 1/Phase 2 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 February 9, 2017 February 22, 2023
NCT03059238 Completed Phase 3 Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure September 2016 March 2019
NCT03111732 Completed Phase 2 Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) June 14, 2017 November 8, 2021
NCT03131778 Completed N/A The Inflammatory Response to Stress and Angiogenesis in Liver Resection April 1, 2010 June 30, 2011
NCT03153332 Completed Value of 3D Printing for Comprehension of Liver Surgical Anatomy July 1, 2017 January 10, 2018
NCT03164382 Completed Phase 3 Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma March 1, 2017 November 30, 2020
NCT03168230 Completed Impact of PVE on Patient's Long-term Survival, Complications and Cancer Recurrence. February 27, 2004 May 21, 2016
NCT03183219 Completed Phase 1/Phase 2 Safety and Efficiency of γδ T Cell Against Liver Cancer June 15, 2017 June 15, 2019
NCT03199586 Completed Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies December 21, 2017 May 7, 2020
NCT03213314 Completed N/A HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies September 7, 2017 March 31, 2019
NCT03226925 Completed N/A Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies June 30, 2017 June 1, 2019
NCT03256994 Completed CIRSE Registry for SIR-Spheres in France (CIRT-FR) August 1, 2017 July 31, 2022
NCT03317483 Completed DEB-TACE Treatment in 367 Liver Cancer Patients November 12, 2015 December 28, 2016
NCT03338062 Completed N/A A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy June 13, 2017 September 2, 2019
NCT03405909 Completed Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study April 21, 2018 April 6, 2019
NCT03515252 Completed Phase 1 Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer April 26, 2005 June 7, 2007
NCT03595345 Completed A Worldwide Score for Hepatocellular Cancer and Liver Transplantation December 15, 2016 October 15, 2018
NCT03602079 Completed Phase 1/Phase 2 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene July 16, 2018 January 12, 2022
NCT03644173 Completed N/A Personal Resilience Empowerment Program Study May 30, 2018 June 14, 2021
NCT03662204 Completed Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors August 23, 2018 March 31, 2022
NCT03723304 Completed The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients March 1, 2018 October 15, 2018
NCT03756597 Completed PAN-study: Pan-Cancer Early Detection Study (PAN) September 26, 2018 July 6, 2023
NCT03784469 Completed N/A Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC February 21, 2018 August 28, 2018
NCT03804593 Completed HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) December 17, 2018 October 31, 2019
NCT03813953 Completed N/A The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver Resection March 6, 2019 August 30, 2019
NCT03888859 Completed Early Phase 1 ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma December 6, 2017 December 8, 2020
NCT03891654 Completed Early Phase 1 Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients August 1, 2019 April 28, 2022
NCT04106453 Completed N/A Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial September 14, 2019 February 4, 2020
NCT04257240 Completed Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury January 1, 2000 December 31, 2012
NCT04269499 Completed N/A Real-time Imaging of Holmium Radioembolization: a Feasibility Study November 11, 2019 May 10, 2021
NCT04272619 Completed N/A Liver Cancer Community Education February 11, 2020 April 6, 2023
NCT04341012 Completed Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases September 10, 2019 September 3, 2021
NCT04413526 Completed Radiofrequency-assisted Liver Resection in Intractable Liver Cancer May 25, 2020 November 18, 2021
NCT04430842 Completed Phase 1 Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S July 20, 2020 December 22, 2022
NCT04476082 Completed Nutrition in Gastrointestinal Tumors June 25, 2020 December 6, 2022
NCT04576572 Completed Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma June 15, 2020 September 30, 2020
NCT04618692 Completed N/A Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation December 2, 2020 March 30, 2023
NCT04707547 Completed Phase 4 Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy October 16, 2019 July 23, 2020
NCT04926376 Completed N/A Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC November 2, 2021 November 13, 2023
NCT05176860 Completed N/A Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy December 20, 2022 July 30, 2023
NCT05183776 Completed N/A Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT July 12, 2022 August 8, 2023
NCT05200195 Completed Deep Learning Model for the Prediction of Post-LT HCC Recurrence January 15, 2020 March 15, 2022
NCT05471674 Completed Phase 2 Neoadjuvant Anti-PD1 in HCC July 3, 2020 December 31, 2022
NCT05475054 Completed Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes December 1, 2020 July 22, 2022
NCT05532319 Completed Phase 2 HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC February 1, 2022 December 30, 2023
NCT05540925 Completed Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer January 1, 2022 September 1, 2022
NCT05638048 Completed N/A Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients July 10, 2022 January 10, 2023
NCT05732181 Completed N/A The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation May 9, 2017 April 30, 2018
NCT05804799 Completed Liver CT Dose Reduction With Deep Learning Based Reconstruction January 1, 2021 December 31, 2022
NCT05989789 Completed N/A Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients June 15, 2020 June 30, 2021
NCT06013774 Completed N/A Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure May 25, 2021 January 16, 2023
NCT04466124 Enrolling by invitation Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy September 21, 2018 August 31, 2028
NCT03228095 Enrolling by invitation Volatiles in Breath and Headspace Analysis - Diagnostic Markers July 24, 2017 December 31, 2025
NCT05443230 Enrolling by invitation Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment June 1, 2022 December 1, 2024
NCT05872828 Enrolling by invitation Cross-sectional Study of Chinese Liver Cancer Patients April 1, 2023 April 30, 2024
NCT05339919 Enrolling by invitation Relationship Between Liver Cancer and Sarcopenia May 1, 2020 August 28, 2025
NCT03739164 Enrolling by invitation Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) July 18, 2018 December 31, 2024
NCT05600933 Enrolling by invitation Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment May 15, 2023 June 15, 2033
NCT05443217 Enrolling by invitation Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments June 1, 2022 December 1, 2024
NCT00589030 No longer available Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery April 2007 September 2014
NCT02960620 No longer available Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT05876052 Not yet recruiting N/A HOPE to Reduce Tumour Recurrence After LT In Patients With HCC May 2023 May 2025
NCT06353126 Not yet recruiting Phase 2 DEB-TACE Prior to Liver Transplantation in the Treatment of HCC June 1, 2024 July 1, 2027
NCT04690972 Not yet recruiting "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". December 20, 2020 December 4, 2028
NCT06384417 Not yet recruiting N/A Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 June 2024 December 2026
NCT05744219 Not yet recruiting Phase 3 Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial August 1, 2023 March 30, 2028
NCT05095714 Not yet recruiting N/A FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. December 1, 2021 December 1, 2027
NCT06196294 Not yet recruiting Phase 1 GPC3/Mesothelin-CAR-γδT Cells Against Cancers January 10, 2024 December 30, 2033
NCT04053231 Not yet recruiting Hepatocarcinoma Recurrence on the Liver Study - Part2 September 2019 May 2034
NCT06356623 Not yet recruiting A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer May 5, 2024 August 6, 2024
NCT06440018 Not yet recruiting INSPIRE: A Multi-Cancer Early Detection Study June 20, 2024 February 28, 2025
NCT05184790 Not yet recruiting LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology January 31, 2024 January 31, 2026
NCT06263088 Not yet recruiting N/A EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. July 2024 June 30, 2026
NCT06345508 Not yet recruiting Early Detection of Liver Cancer by QUS April 2024 December 2029
NCT03946852 Not yet recruiting N/A Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation June 2019 June 2026
NCT04825470 Not yet recruiting N/A Liver Transplantation for Unresectable GIST Liver Metastases May 2022 December 2025
NCT05709886 Not yet recruiting N/A A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver Cancer February 28, 2023 March 31, 2025
NCT05694949 Not yet recruiting Main Postoperative Complications After COVID-19 February 1, 2023 February 1, 2024
NCT05781581 Not yet recruiting A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection March 19, 2023 December 31, 2024
NCT04931420 Not yet recruiting Phase 2 Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels September 30, 2025 November 1, 2027
NCT06341270 Not yet recruiting N/A Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy April 20, 2024 December 20, 2026
NCT04715191 Not yet recruiting Phase 1 Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors July 3, 2024 July 3, 2041
NCT05723705 Not yet recruiting Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) April 2023 December 2025
NCT06408623 Not yet recruiting Phase 2 Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer May 15, 2024 May 15, 2026
NCT06369597 Not yet recruiting N/A A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery April 15, 2024 March 31, 2025
NCT06181318 Not yet recruiting Quantitative MRI and Outcomes of Liver Resection February 1, 2024 April 30, 2025
NCT05942560 Not yet recruiting N/A Effects of CBT-Based Intervention Among Patients With Liver Cancer December 30, 2023 June 30, 2029
NCT06050200 Not yet recruiting N/A TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery May 2024 May 2029
NCT05951231 Not yet recruiting N/A Liver Transplantation After ex Vivo Liver Perfusion February 2024 February 2029
NCT06409637 Not yet recruiting Phase 1/Phase 2 FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation January 1, 2025 December 31, 2029
NCT06175845 Not yet recruiting N/A Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma February 2024 July 2026
NCT05964361 Recruiting Phase 1/Phase 2 First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients December 6, 2023 September 1, 2025
NCT05992220 Recruiting Phase 2 Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion October 22, 2022 March 2026
NCT03223818 Recruiting N/A The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients July 1, 2018 July 1, 2025
NCT05996666 Recruiting Primary Liver Cancer Early Detection July 1, 2023 December 2023
NCT06003218 Recruiting N/A Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation October 16, 2023 August 2024
NCT06006338 Recruiting Phase 1 3D Printed Models for Liver Surgery September 15, 2023 February 29, 2024
NCT06447064 Recruiting Cancer Loyalty Card Study 2 (CLOCS-2) April 29, 2024 March 31, 2027
NCT06406244 Recruiting N/A Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy April 20, 2024 October 20, 2026
NCT05411133 Recruiting Phase 1 Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients May 30, 2022 August 2025
NCT05738447 Recruiting Phase 1 Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma February 15, 2023 January 1, 2025
NCT06036563 Recruiting Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing September 1, 2023 December 2025
NCT05743842 Recruiting N/A TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning March 14, 2023 December 31, 2027
NCT03445585 Recruiting Biobank for Cholestatic Liver Diseases. January 2017 January 2050
NCT05394246 Recruiting N/A Fluorescent-labeled IgG for Liver Tumor Detection May 20, 2022 June 30, 2025
NCT05633342 Recruiting Project CADENCE (CAncer Detected Early caN be CurEd) July 7, 2022 May 2025
NCT05360420 Recruiting N/A Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure October 26, 2022 December 31, 2024
NCT05342350 Recruiting International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy April 15, 2022 July 1, 2032
NCT06084234 Recruiting Phase 4 National Liver Cancer Screening Trial December 26, 2023 December 31, 2034
NCT06084299 Recruiting Phase 1 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer May 27, 2020 August 30, 2026
NCT01494324 Recruiting N/A Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome October 27, 2009 October 2024
NCT06091930 Recruiting Phase 1 A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 January 31, 2024 February 11, 2027
NCT05281211 Recruiting N/A Nutrition and Exercise Prehabilitation to Reduce Morbidity Following Major Liver Surgery in Sarcopenic Patients March 15, 2022 February 15, 2025
NCT06114082 Recruiting Phase 2 TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX) April 28, 2023 December 2025
NCT05199259 Recruiting Multi-analyte Blood Test Clinical Trial March 1, 2022 March 2025
NCT05192460 Recruiting N/A Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer March 28, 2022 June 2025
NCT04825834 Recruiting DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) March 22, 2021 May 31, 2026
NCT06130436 Recruiting N/A Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy October 25, 2023 September 2025
NCT05622136 Recruiting Phase 2 Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma September 10, 2023 June 2025
NCT06139042 Recruiting Early-stage Detection of LIver, Biliary tRAct and pancReatic Cancers November 1, 2023 December 31, 2025
NCT06342323 Recruiting The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy October 8, 2023 October 7, 2025
NCT06141564 Recruiting Detect and Expunge Concealed Tumors of the Liver October 16, 2023 October 1, 2026
NCT06146127 Recruiting Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma January 15, 2001 January 30, 2025
NCT00373347 Recruiting Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma November 2004 December 2025
NCT06173466 Recruiting Phase 4 Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone December 15, 2023 May 29, 2024
NCT05160740 Recruiting N/A Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer September 23, 2021 December 31, 2025
NCT03844399 Recruiting (3D) Ultrasound Imaging Liver and Kidney October 3, 2020 September 2024
NCT06178926 Recruiting N/A Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation August 1, 2023 December 30, 2024
NCT05717400 Recruiting Phase 4 Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy February 7, 2023 October 31, 2026
NCT05153785 Recruiting Phase 2/Phase 3 Perioperative Intravenous Lidocaine in Liver Surgery November 15, 2021 December 31, 2026
NCT00451022 Recruiting Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies September 13, 2004
NCT03949231 Recruiting Phase 3 Infusion of PD1/PDL1 Inhibitor Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma January 1, 2019 January 2, 2028
NCT05598268 Recruiting Phase 1/Phase 2 A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. March 1, 2022 December 2024
NCT05146297 Recruiting N/A Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials December 24, 2022 April 2025
NCT03958019 Recruiting N/A Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer January 25, 2022 December 1, 2024
NCT05128032 Recruiting N/A Pressure-enabled Delivery in Radioembolization (TriNav Study) March 1, 2022 June 1, 2025
NCT03981497 Recruiting Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms February 28, 2018 December 31, 2030
NCT04028479 Recruiting The Registry of Oncology Outcomes Associated With Testing and Treatment May 5, 2021 October 1, 2031
NCT05064553 Recruiting ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk July 26, 2021 April 2026
NCT05767697 Recruiting Genomics and Prognosis in GI Cancers April 15, 2020 December 31, 2025
NCT04075305 Recruiting The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study February 1, 2019 May 1, 2025
NCT05044065 Recruiting N/A Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) May 1, 2022 December 31, 2024
NCT06179602 Recruiting Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors January 1, 2024 January 1, 2028
NCT04933435 Recruiting N/A Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients November 12, 2020 November 2025
NCT04107766 Recruiting NOLA (NeuWave Observational Liver Ablation) Registry January 15, 2020 December 31, 2027
NCT04134559 Recruiting Phase 2 Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma November 1, 2020 January 1, 2025
NCT04145141 Recruiting National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer July 28, 2021 December 31, 2025
NCT04907643 Recruiting N/A Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes October 5, 2021 March 2026
NCT04874519 Recruiting Registry to Collect Health Information Related to Fibrolamellar Cancer November 24, 2021 April 30, 2025
NCT04868149 Recruiting N/A Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS September 2, 2020 July 31, 2024
NCT04172753 Recruiting N/A Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac May 9, 2018 May 9, 2027
NCT04843176 Recruiting N/A Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT March 19, 2021 June 30, 2026
NCT04195438 Recruiting N/A Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy May 7, 2014 June 30, 2026
NCT04842812 Recruiting Phase 1 Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors January 1, 2021 January 1, 2035
NCT05187338 Recruiting Phase 1/Phase 2 Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors November 1, 2021 October 30, 2025
NCT04769713 Recruiting Phase 4 Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures November 23, 2021 September 30, 2023
NCT05517811 Recruiting Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection June 1, 2022 July 31, 2024
NCT04731558 Recruiting Phase 4 Pre- vs Postoperative Thromboprophylaxis for Liver Resection February 10, 2021 March 2025
NCT06212700 Recruiting N/A PRIORITY-CONNECT 2 Pilot Trial February 12, 2024 December 22, 2025
NCT05718882 Recruiting N/A Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC July 1, 2023 December 31, 2025
NCT04288323 Recruiting Phase 4 Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis April 27, 2018 July 30, 2024
NCT05719480 Recruiting A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer November 20, 2022 December 20, 2025
NCT06227728 Recruiting Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. March 22, 2024 December 31, 2026
NCT06326502 Recruiting Phase 1 A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma February 7, 2024 June 7, 2027
NCT04371042 Recruiting PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies September 1, 2019 December 31, 2035
NCT04377932 Recruiting Phase 1 Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors December 8, 2021 February 1, 2040
NCT04409340 Recruiting Viscoelasticity Imaging to Assess Liver Cancer October 5, 2020 December 22, 2023
NCT05806333 Recruiting N/A [18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity June 1, 2022 June 1, 2023
NCT05497453 Recruiting Phase 1/Phase 2 A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene August 19, 2022 December 2028
NCT05492136 Recruiting N/A Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? November 1, 2023 December 31, 2027
NCT06251115 Recruiting N/A Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer January 26, 2024 October 30, 2025
NCT06257030 Recruiting The AMARA (As Much As Reasonably Achievable) Study February 5, 2024 February 5, 2027
NCT04445532 Recruiting Hepatobiliary Tumors Tissue Samples Acquisition October 11, 2020 June 1, 2025
NCT05816837 Recruiting Displacement Distance and Stabilization Time for Liver Fiducial Marker April 20, 2022 April 19, 2024
NCT04657042 Recruiting 4D-MRI for Precision Medicine November 5, 2020 December 31, 2025
NCT05829057 Recruiting Phase 1 The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 May 23, 2023 June 21, 2025
NCT04634357 Recruiting Phase 1/Phase 2 ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma July 19, 2022 January 31, 2028
NCT04545957 Recruiting N/A Jump: MR Simulation For Radiation Therapy Master Protocol October 14, 2020 October 22, 2026
NCT06289712 Recruiting Evaluation of the Ablation of Hepatic Lesions by Electroporation November 23, 2023 May 23, 2025
NCT05850130 Recruiting N/A Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients November 22, 2023 December 2027
NCT05860374 Recruiting Early Phase 1 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors March 2, 2023 March 2, 2026
NCT02853500 Recruiting N/A Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies July 2016 July 2027
NCT06363123 Recruiting Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis March 29, 2024 April 2025
NCT00034216 Recruiting Collection of Blood From Patients With Cancer July 16, 2002
NCT05638269 Recruiting A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China March 1, 2022 December 2025
NCT05724563 Recruiting Phase 2 Domvanalimab and Zimberelimab in Advanced Liver Cancers June 1, 2023 June 1, 2027
NCT05462314 Recruiting Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies March 29, 2022 December 2025
NCT05727787 Recruiting N/A vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC February 23, 2023 February 28, 2025
NCT05886075 Recruiting Early Phase 1 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors March 30, 2023 March 2025
NCT05913141 Recruiting PDO/PDO-TIL/PDOTS for Drug Screen June 2023 June 2026
NCT02012699 Recruiting Integrated Cancer Repository for Cancer Research November 1, 2013 December 2099
NCT05926336 Recruiting Phase 4 The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action May 23, 2023 July 2026
NCT05444478 Recruiting N/A Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma July 1, 2022 July 1, 2027
NCT05953337 Recruiting N/A Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) September 21, 2023 October 2025
NCT00896467 Terminated Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy September 2007 November 2010
NCT02575339 Terminated Phase 1/Phase 2 MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma July 18, 2016 November 24, 2020
NCT02618447 Terminated N/A 4D Phase Contrast MR: Hypertrophy in Liver Cancer August 5, 2014 February 4, 2016
NCT02721056 Terminated Phase 1/Phase 2 NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers January 28, 2016 May 6, 2020
NCT02722616 Terminated N/A Ultrasound Monitoring of Abdominal Soft Tissue May 2016 October 28, 2022
NCT02893982 Terminated Phase 1 High Dose Rate Brachyablation of Primary Liver Lesions November 9, 2017 March 16, 2020
NCT02966223 Terminated N/A A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver August 17, 2017 April 24, 2020
NCT00030511 Terminated Phase 2 Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer October 2001
NCT03026803 Terminated Phase 2 A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer November 2006 October 2014
NCT00003147 Terminated Phase 1 Gene Therapy in Treating Patients With Cancer of The Liver February 1998
NCT03349255 Terminated Phase 1 Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma October 6, 2017 January 10, 2019
NCT03396705 Terminated Liver Regeneration September 12, 2017 March 19, 2019
NCT00019604 Terminated Phase 2 Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer August 1998 January 2009
NCT03516695 Terminated RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry February 23, 2018 December 12, 2018
NCT00005997 Terminated Phase 2 Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer April 1999 November 2005
NCT03753789 Terminated N/A Ablation Confirmation Study November 5, 2019 October 12, 2022
NCT00387348 Terminated Phase 3 Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer March 2006 April 2011
NCT00426829 Terminated Phase 1 Proton Therapy and Bevacizumab for Primary Liver Tumors May 2007 November 2009
NCT00469963 Terminated N/A Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery December 2003 April 2007
NCT03998033 Terminated Phase 1 Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma May 30, 2019 December 31, 2020
NCT00495625 Terminated Phase 2 Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) October 2006 December 2010
NCT00524316 Terminated Phase 2 Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery April 2007 May 2014
NCT04150874 Terminated Early Phase 1 Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE February 19, 2020 May 14, 2021
NCT00568308 Terminated Phase 3 Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma December 2007 July 2008
NCT00185874 Terminated Phase 1 Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases January 2004 October 2007
NCT00623077 Terminated Phase 1 MT2004-30: Tomotherapy for Solid Tumors August 2005 October 2016
NCT00658593 Terminated Phase 3 Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer October 10, 2008 January 18, 2011
NCT00669136 Terminated Phase 1 Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma June 2009 March 2013
NCT00767468 Terminated Phase 1 Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis October 2008 November 2010
NCT00767936 Terminated Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma March 2008 September 2013
NCT00768001 Terminated Genetic Analysis of Liver Cancer June 2008 October 2011
NCT00788125 Terminated Phase 1/Phase 2 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors September 3, 2008 July 30, 2022
NCT04502082 Terminated Phase 1/Phase 2 Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) April 14, 2021 June 20, 2023
NCT00873002 Terminated Phase 1 Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery March 2009 June 2010
NCT04589884 Terminated Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment September 22, 2020 October 15, 2021
NCT00003926 Terminated Phase 1 Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors November 1998 August 2003
NCT00903396 Terminated Phase 2 Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer September 2009 May 2013
NCT01005875 Terminated N/A Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma November 2009 June 2013
NCT01009801 Terminated Phase 1/Phase 2 Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer February 2010 June 2015
NCT01030757 Terminated Phase 2 Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver June 2009 May 2013
NCT01071434 Terminated Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors February 2009 September 2010
NCT01079767 Terminated Phase 2 Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis January 2010
NCT00151671 Terminated Phase 2/Phase 3 Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer April 2003 September 2008
NCT01151761 Terminated Phase 2 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation January 2011 July 2012
NCT01238653 Terminated Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures November 2010 July 2012
NCT05184283 Terminated Utilization of MAsS in Patients Undergoing LT for HCC June 16, 2022 November 29, 2023
NCT01334710 Terminated Phase 2 A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer March 2011 December 2011
NCT01402908 Terminated Phase 3 A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection August 2011 January 2015
NCT05363605 Terminated Phase 1/Phase 2 A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours April 20, 2022 September 8, 2023
NCT01862718 Terminated Phase 1 Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms November 19, 2013 November 5, 2019
NCT02102971 Terminated Observational Study of Biomarker During Liver Surgery October 2014 June 6, 2019
NCT01178801 Unknown status Sharable Knowledge Mining Platform March 2010 March 2013
NCT05369988 Unknown status VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY July 1, 2022 April 1, 2023
NCT03475966 Unknown status N/A Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program February 22, 2017 June 30, 2022
NCT01813942 Unknown status Platform for Medical Information Extraction From Incomplete Data March 2013 March 2016
NCT00079027 Unknown status Phase 3 Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) April 2004
NCT05430841 Unknown status N/A Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT June 1, 2022 December 31, 2023
NCT01882946 Unknown status Phase 1/Phase 2 Safety and Efficacy Study of DCVax-Direct in Solid Tumors June 2013
NCT03184493 Unknown status Phase 3 Celebrex and Metformin for Postoperative Hepatocellular Carcinoma June 2, 2017 June 2021
NCT03166683 Unknown status N/A Standard of Care Versus Hemopatch® During Liver Resection December 2017 September 2020
NCT00027768 Unknown status Phase 3 Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer June 2001
NCT03026452 Unknown status Phase 1/Phase 2 Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer January 2013 December 2018
NCT02461979 Unknown status N/A The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis February 2015 December 2022
NCT02133079 Unknown status Phase 1/Phase 2 Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 March 2012 November 2019
NCT02169765 Unknown status Phase 3 HR Versus RFA for Early Stage HCC August 1, 2020 December 30, 2022
NCT02811666 Unknown status N/A Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers November 2016 November 2019
NCT00003044 Unknown status Phase 2 Chemotherapy in Treating Patients With Liver Cancer September 1996
NCT04653701 Unknown status Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC November 14, 2020 February 20, 2022
NCT00183885 Unknown status Phase 2 A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma October 18, 2004 May 28, 2019
NCT04476641 Unknown status Phase 2 A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors May 6, 2016 December 31, 2022
NCT04348643 Unknown status Phase 1/Phase 2 Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer February 20, 2020 April 30, 2024
NCT04705194 Unknown status Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging July 8, 2019 June 1, 2022
NCT00728078 Unknown status Phase 2/Phase 3 Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma July 2008 July 2011
NCT04309747 Unknown status N/A A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer April 1, 2020 December 1, 2022
NCT04739501 Unknown status Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Study of Different Outcomes and Their Predictive Factors December 1, 2020 March 30, 2022
NCT04215861 Unknown status Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy October 1, 2019 October 2021
NCT02232490 Unknown status Phase 3 Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L January 2015 December 2019
NCT00077389 Unknown status Phase 2 Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma January 2004
NCT04206254 Unknown status Phase 2/Phase 3 GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer December 19, 2019 August 5, 2023
NCT04186234 Unknown status N/A SBRT for Liver Cancer Before Liver Transplantation January 1, 2015 December 31, 2022
NCT00557024 Unknown status Phase 4 Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma November 2007 July 2010
NCT00556803 Unknown status Phase 4 TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma November 2007 June 2010
NCT00555334 Unknown status Phase 4 Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma November 2007 December 2010
NCT02662348 Unknown status Phase 1 T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System February 2016 November 2017
NCT00554905 Unknown status Phase 4 Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma October 2006 June 2009
NCT00553683 Unknown status Phase 1/Phase 2 Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer October 2007 July 2014
NCT04107324 Unknown status N/A ARAPS Study on Accelerated Liver Regeneration January 1, 2020 May 1, 2023
NCT00152087 Unknown status Phase 2 A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible. October 2002 June 2005
NCT02646137 Unknown status Phase 3 Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma January 2015 December 2023
NCT02632188 Unknown status Phase 1/Phase 2 Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma September 2015 September 2017
NCT05032014 Unknown status N/A Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer November 19, 2021 December 30, 2023
NCT04221347 Unknown status Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC October 1, 2017 December 31, 2022
NCT00514930 Unknown status Phase 1/Phase 2 Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver February 2007 August 2007
NCT01182272 Unknown status Phase 2 Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery May 2010
NCT04014478 Unknown status N/A A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain July 15, 2019 July 15, 2021
NCT05123209 Unknown status Phase 1 Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors August 24, 2021 August 30, 2023
NCT03965546 Unknown status Early Phase 1 ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer May 30, 2019 June 2022
NCT00471484 Unknown status Phase 2 Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery March 2007
NCT01230697 Unknown status Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM) June 2010 September 2011
NCT00003296 Unknown status Phase 2 Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer January 1998
NCT03843229 Unknown status Phase 4 Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer January 27, 2019 September 1, 2020
NCT03766633 Unknown status Accuracy of the LiverVision® Semi-automated Liver Volumetry Software April 29, 2018 March 31, 2021
NCT02321579 Unknown status N/A Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities December 2014 July 2017
NCT01292330 Unknown status N/A A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support January 2010 November 2011
NCT00287976 Unknown status Phase 2 Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma April 2003
NCT01324076 Unknown status Phase 3 Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery November 2010
NCT02324127 Unknown status N/A Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer October 2012 December 2014
NCT01341210 Unknown status Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients February 2011 February 2014
NCT00282100 Unknown status Phase 2 Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma December 2005 September 2019
NCT00276705 Unknown status Phase 2 Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer June 2005
NCT01388101 Unknown status N/A Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor) September 2010 October 2013
NCT03668418 Unknown status Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos June 1, 2018 May 31, 2022
NCT00247260 Unknown status Phase 2 Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma October 2005 February 2007
NCT02568748 Unknown status Phase 3 Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC October 2015 October 2019
NCT05322187 Unknown status Phase 2/Phase 3 Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy April 10, 2022 December 31, 2023
NCT03620916 Unknown status N/A Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection August 17, 2018 January 2019
NCT05339581 Unknown status N/A IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation May 20, 2022 May 31, 2024
NCT03592706 Unknown status Phase 2/Phase 3 Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy December 2009 August 2021
NCT03585166 Unknown status Nursing Fro Laparoscopic vs. Open Hepatectomy October 1, 2017 October 31, 2023
NCT05343832 Unknown status Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients November 29, 2021 April 25, 2023
NCT00006198 Unknown status Phase 2 Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
NCT02563158 Unknown status N/A Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC January 2016 January 2019
NCT05369650 Unknown status N/A To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients July 27, 2019 September 27, 2022
NCT00605800 Withdrawn Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function March 2006 March 2009
NCT00093548 Withdrawn Phase 1/Phase 2 Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
NCT01618253 Withdrawn Phase 1 Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma June 2012 June 2016
NCT05471401 Withdrawn N/A GI Organ Tracking Via Balloon Applicators April 25, 2023 May 31, 2025
NCT02989870 Withdrawn Phase 1 Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma March 27, 2017 October 15, 2018
NCT02261844 Withdrawn Phase 1/Phase 2 Resveratrol and Human Hepatocyte Function in Cancer December 2015 June 2016
NCT00039078 Withdrawn Phase 2 Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery August 2000 August 2000
NCT00020774 Withdrawn Phase 2 SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer October 1998
NCT00430313 Withdrawn N/A Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin January 4, 2007 August 10, 2022
NCT00244348 Withdrawn Phase 1/Phase 2 Hepatic Artery Infusion With Oxaliplatin October 2005 August 2015
NCT00899002 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer July 2007 May 2009
NCT01864070 Withdrawn Phase 1 Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease May 2014
NCT00293436 Withdrawn Phase 1/Phase 2 Celecoxib and Erlotinib in Treating Patients With Liver Cancer January 2005
NCT04511793 Withdrawn N/A Hepatic Artery Infusion (HAI) Program at Duke University December 11, 2020 December 31, 2022
NCT00624962 Withdrawn N/A Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors March 2006 January 2008
NCT05510427 Withdrawn Phase 1 Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification August 7, 2023 August 7, 2023
NCT02772575 Withdrawn A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE) April 2016
NCT00892255 Withdrawn Microwave Ablation of Resectable Liver Tumors April 2009 April 2009
NCT02599909 Withdrawn Gut Microbiota in People With Hepatocellular Carcinoma (HCC) November 6, 2015 September 14, 2018
NCT05039736 Withdrawn Phase 2 A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy February 24, 2023 May 3, 2023
NCT04105062 Withdrawn Phase 1/Phase 2 LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery December 31, 2021 December 31, 2023
NCT03063840 Withdrawn N/A Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels July 2016 July 27, 2018
NCT00003714 Withdrawn Phase 2 Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
Disase is a (Disease Ontology)
DOID:0080355
Cross Reference ID (Disease Ontology)
ICD10CM:C22.0
Cross Reference ID (Disease Ontology)
ICD10CM:C22.9
Cross Reference ID (Disease Ontology)
ICD9CM:155.0
Cross Reference ID (Disease Ontology)
ICD9CM:155.2
Cross Reference ID (Disease Ontology)
MESH:D008113
Cross Reference ID (Disease Ontology)
NCI:C34803
Cross Reference ID (Disease Ontology)
NCI:C7692
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:126851005
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:187771009
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:93870000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0023903
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0024620
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0345904
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0854795
Exact Synonym (Disease Ontology)
Ca liver - primary
Exact Synonym (Disease Ontology)
hepatic cancer
Exact Synonym (Disease Ontology)
hepatic neoplasm
Exact Synonym (Disease Ontology)
malignant hepato-biliary neoplasm
Exact Synonym (Disease Ontology)
malignant neoplasm of liver
Exact Synonym (Disease Ontology)
malignant neoplasm of liver, not specified as primary or secondary
Exact Synonym (Disease Ontology)
malignant neoplasm of liver, primary
Exact Synonym (Disease Ontology)
malignant tumor of liver
Exact Synonym (Disease Ontology)
neoplasm of liver
Exact Synonym (Disease Ontology)
non-resectable primary hepatic malignant neoplasm
Exact Synonym (Disease Ontology)
primary liver cancer
Exact Synonym (Disease Ontology)
primary malignant neoplasm of liver
Exact Synonym (Disease Ontology)
Resectable malignant neoplasm of Liver
Exact Synonym (Disease Ontology)
resectable malignant neoplasm of the liver